NHL
Clinical trials for NHL explained in plain language.
Never miss a new study
Get alerted when new NHL trials appear
Sign up with your email to follow new studies for NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to shrink tough blood cancers
Disease control CompletedThis early-phase study tested a new three-drug combination (VVIP) for adults with aggressive non-Hodgkin lymphomas that have returned or not responded to at least two prior treatments. The main goals were to find the safest dose and see if the treatment could make the cancer disa…
Matched conditions: NHL
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New engineered cell therapy tested in kids with Tough-to-Treat cancers
Disease control CompletedThis study tested a new type of personalized cell therapy for children and young adults whose leukemia or lymphoma had come back or did not respond to standard treatments. Researchers collected a patient's own immune cells, genetically modified them in a lab to recognize a protei…
Matched conditions: NHL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC